160 related articles for article (PubMed ID: 30153792)
1. Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis.
Al-Mozaini M; Alrahbeni T; Al-Mograbi R; Alrajhi A
BMC Infect Dis; 2018 Aug; 18(1):425. PubMed ID: 30153792
[TBL] [Abstract][Full Text] [Related]
2. Genotyping and antiretroviral drug resistance of human immunodeficiency Virus-1 in Jazan, Saudi Arabia.
Zaki EA; El-Daly MM; Abdulhaq A; Al-Subhi TL; Hassan AM; El-Kafrawy SA; Alhazmi MM; Darraj MA; Azhar EI
Medicine (Baltimore); 2020 Dec; 99(49):e23274. PubMed ID: 33285702
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia.
Jamjoom GA; Azhar EI; Madani TA; Hindawi SI; Bakhsh HA; Damanhouri GA
Saudi Med J; 2010 Sep; 31(9):987-92. PubMed ID: 20844809
[TBL] [Abstract][Full Text] [Related]
5. Frequency and diversity of human immunodeficiency virus type 1 mutations associated with antiretroviral resistance among patients from Southern Brazil failing highly active antiretroviral therapy (HAART).
Figueiredo Saad F; Kaminami Morimoto H; Wiechmann SL; Bonametti AM; Ueda LT; Matsuo T; Reiche EM
Int J Mol Med; 2010 Oct; 26(4):585-93. PubMed ID: 20818500
[TBL] [Abstract][Full Text] [Related]
6. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection in Oman: antiretroviral therapy and frequencies of drug resistance mutations.
Al Dhahry SH; Scrimgeour EM; Al Suwaid AR; Al Lawati MR; El Khatim HS; Al Kobaisi MF; Merigan TC
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1166-72. PubMed ID: 15588338
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
9. Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.
Torti C; Moretti F; Uccelli MC; Tirelli V; Quiros-Roldan E; Gargiulo F; Carosi G
Med Sci Monit; 2003 Apr; 9(4):CS16-9. PubMed ID: 12709675
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
[TBL] [Abstract][Full Text] [Related]
11. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
14. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
15. [HIV-1 resistance to antiretroviral drugs in pregnant women from Buenos Aires metropolitan area].
Zapiola I; Cecchini D; Fernández Giuliano S; Martínez M; Rodríguez C; Bouzas MB
Medicina (B Aires); 2016; 76(6):349-354. PubMed ID: 27959842
[TBL] [Abstract][Full Text] [Related]
16. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010.
Hussain F; Iqbal S; Mehmood A; Bazarbashi S; ElHassan T; Chaudhri N
Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):58-64. PubMed ID: 23756719
[TBL] [Abstract][Full Text] [Related]
17. Late presentation and transmitted drug resistance mutations in new HIV-1 diagnoses in Detroit.
Huaman MA; Aguilar J; Baxa D; Golembieski A; Brar I; Markowitz N
Int J Infect Dis; 2011 Nov; 15(11):e764-8. PubMed ID: 21840743
[TBL] [Abstract][Full Text] [Related]
18. Distinct mutational drug resistance profiles of HIV-1 RNA in plasma and culture isolates of patients receiving antiretroviral therapy.
Debiaggi M; Bruno R; Sacchi P; Achilli G; Romero E; Filice G
Intervirology; 2002; 45(1):52-5. PubMed ID: 11937771
[TBL] [Abstract][Full Text] [Related]
19. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
